Feasibility Studies, Home Exercise Program, PD - Parkinson's Disease
Conditions
Brief summary
This study aims to test whether patients with Parkinson's disease can safely and effectively use a home-based exercise program guided by videos. Participants will follow video instructions for exercises at home while their movements are monitored by a camera, which provides real-time feedback. The study will check how well participants complete the exercises, their satisfaction with the program, and any changes in clinical function. The goal is to see if this type of home exercise can help patients increase their activity levels without significant side effects.
Interventions
BEHAVIORALHome-based self-exercise feedback program using video
Participants follow a 6-week home-based exercise program using video-guided instructions and the iPixel exercise feedback system, which monitors movements in real-time and provides corrective feedback. The program includes: Stretching exercises, Strength training, Balance exercises, Aerobic exercises, LSVT-specific exercises. Participants are instructed to complete sessions at least 5 times per week, 40 minutes per session. Additionally, weekly 30-minute in-person rehabilitation sessions are conducted to adjust the next week's exercise intensity based on each participant's functional level.
Sponsors
Seoul National University Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
This is a single-arm, prospective interventional study in which all participants receive the same 6-week home-based video-guided exercise program. There is no control or comparator group, and the primary goal is to assess feasibility, adherence, safety, and functional outcomes in patients with Idiopathic Parkinson's Disease. Participants are monitored throughout the study period, with weekly 30-minute in-person rehabilitation sessions to adjust exercise intensity based on functional level. Assessments are conducted both before and immediately after the intervention, including exercise adherence, patient satisfaction, and clinical function evaluations.
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults aged 19 years or older, clinically diagnosed with Idiopathic Parkinson's Disease (PD) according to the Movement Disorder Society (MDS) clinical diagnostic criteria * Patients at Hoehn and Yahr stage 1-2.5 * Patients on stable dopaminergic therapy with no changes in the past 1 month * Patients receiving Lee Silverman Voice Treatment (LSVT) rehabilitation therapy once weekly as outpatients * Patients who have voluntarily provided informed consent to participate in the study
Exclusion criteria
* Patients diagnosed with atypical parkinsonism * Patients with musculoskeletal problems that make participation in rehabilitation difficult * Patients who have limited access to the video-based home exercise feedback program
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Part III (Motor Examination) | From enrollment to the end of treatment at 6 weeks | 0 to 108, with higher scores indicating worse motor function. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Modified Hoehn and Yahr sacle | From enrollment to the end of treatment at 6 weeks | Modified Hoehn and Yahr Scale Score range: 0 to 5, with higher scores indicating more severe disease stage. |
| Berg Balance Scale | From enrollment to the end of treatment at 6 weeks | 0 to 56, with higher scores indicating better balance ability. |
| Functional Gait Ability | From enrollment to the end of treatment at 6 weeks | 0 to 30, with higher scores indicating better gait function. |
| Freezing of Gait Questionnaire | From enrollment to the end of treatment at 6 weeks | 0 to 24, with higher scores indicating more severe freezing of gait. |
| EuroQol-5 Dimention Questionnaire | From enrollment to the end of treatment at 6 weeks | 0 to 1, with higher scores indicating better health-related quality of life. |
Countries
South Korea
Contacts
CONTACTWon-Seok Kim, MD, PhD
CONTACTSunJeong Gwon, BS
PRINCIPAL_INVESTIGATORWon-Seok Kim, MD, PhD
Seoul National University Bundang Hospital
Outcome results
None listed